Mammoth Biosciences

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

  • 2023 Best Places to Work
WHO WE ARE

We are a team of scientists, entrepreneurs, and dreamers who are building the platform for CRISPR applications of the future.

· Mission 1st

We are developing technologies and products that we are passionate about and that can have a mammoth impact.

· Innovation

Discovery is in our RNA. We stay at the forefront of both patient impact and scientific advancement by combining our creativity with experience to take intelligent risks.

· Accountability

We have the privilege to work with transformative technologies and amazing people, and we have the responsibility to make sure we are having the most positive impact possible both on the world and in our team.

· Execute with Urgency

Patients are counting on us and we make it happen. We focus on the most important and high impact opportunities and do work that matters.

· Inclusion & Diversity

Our Mammoth strength comes from the diversity of nature and of our people.

Full Benefits

We cover 100% of employee benefits for medical, dental, vision and life insurance.

401(k)

Our 401(k) plan includes company matching of employee contributions.

Unlimited Vacation

We have an unlimited vacation policy that allows you to get the rest and relaxation you need to refresh.

Transportation Subsidy

We provide a public transportation commuter subsidy.

Onsite Food and Amenities

We offer several free amenities including snacks and drinks, as well as lunch and dinner.

Happy Hours

We encourage our team to unwind and get to know each other through company happy hours.

NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.
The collaboration, announced Wednesday, aims to make disposable, hand-held diagnostics that are as accurate as lab tests and as easy to use as home pregnancy kits.
Weeks after Mammoth Biosciences announced its CRISPR-based diagnostics test for COVID-19 had a high degree of specificity even for asymptomatic patients, the company has struck a deal with GSK to accelerate development of the test in hopes of getting them in consumer hands as soon as possible.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
Following news of Mammoth Biosciences’ CRISPR diagnostic assay to detect SARS-CoV-2, the company talked at length with BioSpace about this new test and its ramifications.
The Mammoth DETECTR assay was validated in less than two weeks and can deliver results in less than 45 minutes.
The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.
Companies from across the globe provide updates to their business and pipeline.
Pharma, biotech and life sciences organizations strengthen their leadership teams and boards.
JOBS
IN THE PRESS